• Loading metrics

Secretion of Clostridium difficile Toxins A and B Requires the Holin-like Protein TcdE

  • Revathi Govind,

    Affiliations Laboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Paris, France, Division of Biology, Kansas State University, Manhattan, Kansas, United States of America

  • Bruno Dupuy

    Affiliation Laboratoire Pathogenèse des Bactéries Anaérobies, Institut Pasteur, Paris, France

Secretion of Clostridium difficile Toxins A and B Requires the Holin-like Protein TcdE

  • Revathi Govind, 
  • Bruno Dupuy


The pathogenesis of Clostridium difficile, the major cause of antibiotic-associated diarrhea, is mainly associated with the production and activities of two major toxins. In many bacteria, toxins are released into the extracellular environment via the general secretion pathways. C. difficile toxins A and B have no export signature and their secretion is not explainable by cell lysis, suggesting that they might be secreted by an unusual mechanism. The TcdE protein encoded within the C. difficile pathogenicity locus (PaLoc) has predicted structural features similar to those of bacteriophage holin proteins. During many types of phage infection, host lysis is driven by an endolysin that crosses the cytoplasmic membrane through a pore formed by holin oligomerization. We demonstrated that TcdE has a holin-like activity by functionally complementing a λ phage deprived of its holin. Similar to λ holin, TcdE expressed in Escherichia coli and C. difficile formed oligomers in the cytoplamic membrane. A C. difficile tcdE mutant strain grew at the same rate as the wild-type strain, but accumulated a dramatically reduced amount of toxin proteins in the medium. However, the complemented tcdE mutant released the toxins efficiently. There was no difference in the abundance of tcdA and tcdB transcripts or of several cytoplasmic proteins in the mutant and the wild-type strains. In addition, TcdE did not overtly affect membrane integrity of C. difficile in the presence of TcdA/TcdB. Thus, TcdE acts as a holin-like protein to facilitate the release of C. difficile toxins to the extracellular environment, but, unlike the phage holins, does not cause the non-specific release of cytosolic contents. TcdE appears to be the first example of a bacterial protein that releases toxins into the environment by a phage-like system.

Author Summary

Clostridium difficile is the causative agent of antibiotic associated diarrhea and has become the most prevalent cause of infectious nosocomial diarrhea in North America and in several countries in Europe. Most virulent strains of C. difficile produce two high molecular weight toxins that are regarded as the primary virulence factors. The mechanism by which these large toxins are secreted from bacterial cells is not known. Unlike most clostridial toxins, they have no export signature and must be secreted by an unusual system. This work investigated the role of a C. difficile membrane protein TcdE in the release of toxins from the bacterial cell. We showed that C. difficile tcdE mutants were defective in toxin release and present evidence that C. difficile TcdE protein activity is similar to that of bacteriophage holin proteins required for lysis of host cells after intracellular phage development. These results suggest that TcdE helps efficient secretion of toxins by a phage type system. However, unlike phages, TcdE does not induce cell lysis. A detailed, mechanistic understanding of the holin-dependent system that mediates toxin secretion may helpful for the development of strategies for preventing and treating C. difficile infections.


Clostridium difficile, a Gram-positive, anaerobic bacterium, is a major cause of antibiotic-associated diarrhea and pseudomembraneous colitis. C. difficile infections (CDI) are typically induced by treatment with antibiotics that disrupt the normal gastrointestinal microbiota. C. difficile has emerged in the last decade as a formidable enteric pathogen with an increased propensity to cause frequent, severe and recurrent disease [1], [2]. This mainly results from the emergence of new isolates, such as those that have been assigned to the BI/NAP1/027 family, which was first reported in North America and has rapidly spread among various European countries. Pathogenic C. difficile strains usually produce two high molecular weight toxins, TcdB and TcdA, that are the major virulence factors [3]. Both toxins are monoglucosyltransferases that modify the activity of members of host cell Rho family of small GTPases [4], disrupting the actin cytoskeleton of intestinal epithelial cells. TcdA (308 kDa) and TcdB (270 kDa) are among the largest bacterial toxins reported to date. They share 49% amino acid identity and a similar overall structure composed of a receptor-binding domain, a transmembrane domain and a glycosyl transferase domain [5], [6]. Important advances have been made in understanding the regulation of toxin synthesis, their enzymatic activities and their impact on host cell physiology [4], [7][12], but their mode of secretion from the bacteria has been a mystery. Most extracellular proteins carry an N-terminal or C-terminal signal peptide, a Tat-signal peptide or some other clearly definable secretion signal [13]. Interestingly, TcdA and TcdB are secreted without any apparent signal peptide or other recognizable secretion signal. Moreover, bacterial lysis does not seem to explain release of toxin proteins, since Karlsson et al [14] showed that in stationary phase cells 50% of the total toxin protein synthesized is released into the extracellular fluid whereas <1% of typical cytoplasmic proteins is released.

The toxin genes tcdA and tcdB lie within a chromosomal region of 19.6 kb designated the pathogenicity locus (PaLoc) (Figure 1A). The same locus encodes TcdR, an alternative sigma factor that specifically directs transcription from the toxin promoters as well as its own promoter, TcdC, an antagonist of TcdR that prevents the formation of the TcdR-containing RNA polymerase holoenzyme [12], [15], [16], and TcdE, whose function was not known.

Figure 1. PaLoc in C. difficile.

A. Schematic diagram of PaLoc in toxigenic C. difficile strains. In non-toxigenic strains this region is replaced by a short 115 bp sequence. Arrows indicates the positive regulation of tcdR, tcdB and tcdA by σTcdR. B Predicted topology of TcdE and. λS holin Horizontal black bars represent the relative position of Cys 51 in S105 and Cys 29, 56, 79, 111 and 113 in TcdE.

When overexpressed in Escherichia coli, TcdE causes cell death [17]. The tcdE open reading frame potentially encodes a small, hydrophobic protein of 166 amino acids with a short hydrophilic stretch at the N-terminus and a series of charged residues at the C-terminus [17]. TcdE is predicted to contain three transmembrane domains (Figure 1B). These structural features and primary sequence similarities strongly suggest that TcdE is a member of the class I holins of which phage λ S protein is a member. Holins are small membrane proteins encoded by double-stranded DNA phages that are required for the lysis of host cells at a programmed time after completion of intracellular phage development [18], [19]. They form disruptive lesions by oligomerization in the host cell plasma membrane to allow a prophage-encoded endolysin (a muralytic enzyme), to cross the membrane and attack the murein, resulting in cell lysis and release of phage particles [18], [19]. Phage λ S protein is made in two forms. S105 has holin activity, whereas S107, which has two additional amino acid residues at the N-terminus, retards lysis by interfering with the activity of S105.

While most holins are associated with terminal lysis of phage-infected bacteria, some holin-like proteins were also suggested to be responsible for the release of proteins from uninfected bacteria [20][23]. However this supposition has never been tested experimentally and the role of holin-like proteins in protein secretion has yet to be proven. The homology of TcdE to phage holins led us to investigate its possible role in toxin secretion.

In this study, we first showed that TcdE is required for efficient secretion of toxins. Surprisingly, TcdE facilitates release of toxins without inducing cell lysis or general membrane permeability. We then demonstrated that TcdE has a holin-like activity by complementing an E. coli λ lysogen that is defective for the λ holin. Several models for the TcdE-dependent secretion of TcdA/TcdB are suggested taking account of the absence of cell lysis due to TcdE holin activity in the natural host. These results provide the first experimental evidence that a holin-like protein has a role in protein secretion.


TcdE is required for efficient secretion of toxins

We used the ClosTron system recently developed by Heap and coworkers [24] to disrupt the tcdE gene by insertion of a group II intron from pMTL007 (see Materials and Methods). To confirm the disruption, the tcdE-specific primers OBD231 and OBD232 were used to amplify a 550 bp PCR product from the parental JIR8094 DNA, corresponding to the wild type tcdE gene, and a 2.5 kbp product from the mutant DNA, corresponding to the tcdE gene with group II intron inserted within it (Figure 2A). When PCR was carried out using intron-specific primers EBS(U) and ERM along with OBD232 and OBD231, PCR products of 1150 bp and 570 bp respectively could be amplified from tcdE mutant DNA but not from the wild-type strain's DNA (Figure 2A) confirming the insertion of the intron in the tcdE gene. Furthermore, Southern blot analysis confirmed that the intron had inserted in only one DNA region in the tcdE mutant (Figure 2B). The wild-type and the tcdE mutant strains grew similarly in TY broth, but a slightly higher OD600 was seen for the mutant strain compared the wild-type after 16 hrs (Figure 2C). In quantitative reverse transcription-PCR assays the levels of tcdA and tcdB transcripts were the same for the parental and mutant strains (data not shown). This result suggests that intron insertion within tcdE exerts no polar effect on the expression of tcdA, consistent with the fact that tcdA transcription occurs primarily from its own promoter (Figure 1A) [12]. We confirmed by dot blot experiments that the quantity of TcdA detected in total crude extracts of both strains was the same (Figure 2D). However, when we analyzed the culture supernatants, we observed a dramatic reduction in the amount of toxin secreted by the mutant when compared to the wild-type strain (Figure 3A). On the other hand, more toxin accumulated in the cytoplasm of the tcdE mutant than in the wild-type strain in stationary phase cells (Figure 3B). Both observations were confirmed by dot blot analysis with monoclonal antibodies against TcdA and TcdB (Figure 3AB) and Vero cell cytotoxicity assays, which is predominantly toxin B-assessed (Figure S1).

Figure 2. Construction and characterization of the tcdE mutant in C. difficile.

A. PCR verification of the intron insertion using gene-specific primers OBD231 and OBD232 or the intron-specific primer EBS(U) or ERM in association with primers OBD231 or OBD232. B. Southern blot analysis of genomic DNA from C. difficile JIR8094 and tcdE mutant strains with an intron probe. Chromosomal DNA was digested by either EcoRV or HindIII. C. Growth curves of JIR8094 and tcdE mutant in TY medium. D. TcdA Dot blot analysis. The crude lysates prepared by sonication of cells with their supernatants (200 ng proteins) were probed with TcdA monoclonal antibody (PCG4).

Figure 3. Quantification of toxins and lactate dehydrogenase (LDH) activity in parent JIR8094 and tcdE mutant strains.

Toxin titers in the culture supernatants (A) and in cytoplasmic proteins (B) were determined by ELISA and the signal from the test was recorded as absorbance at 450 nm. The data shown are the mean +/− standard error of three replicative samples. Student's t-test was used for statistical analysis. (*) P-value is < to 0.05. Dot blots with monoclonal anti-TcdA and anti-TcdB are shown in the lower panels. Purified TcdA and TcdB were used as controls. C. LDH activity in the cytoplasmic fraction was determined using Promega CytoTox 96 and was measured as micro units calculated in comparison with standards provided in the kit. D. Cytoplasmic proteins collected from a 16 hours old cultures of parental and tcdE mutant strains were analyzed in dot blots using monoclonal antibodies against L7/L12 ribosomal subunits and the RNA polymerase beta subunit.

To confirm that the defect in toxin secretion was due to the disruption of TcdE, we complemented the tcdE mutant with the wild type tcdE gene. Expression of TcdE from its own promoter using a multicopy plasmid was observed to be lethal to C. difficile (see below). Hence we expressed TcdE in the mutant strain using a tightly controlled expression system [25]. The tcdE ORF with a C-terminal 6xHis Tag was cloned downstream of a tetracycline-inducible promoter in the vector pRPF185 to create pRG60 (see Materials and Methods). We first showed that TcdE-6His is expressed in C. difficile cultures induced with 20 ng/ml to 50 ng/ml of ATc (Anhydrotetracycline), a non-antibiotic analog of tetracycline, without affecting cell growth (data not shown). Thus, we induced the C. difficile cultures with ATc (20 ng/ml) to test the effect of TcdE-6His on toxin release in the complemented mutant strain. The tcdE mutant carrying pRG60 along with the control strains JIR8094 and the tcdE mutant carrying the vector pRPF185 were grown for 4 hours to an OD600 of 0.3 in TY broth and induced with ATc. No difference in growth of the three strains could be observed during the first two hours after induction (Figure 4A). However, after more than two hours, the growth rate of the complemented tcdE mutant began to decrease (Figure 4A). Hence, using ELISA, we measured toxin proteins in the supernatant fluid of cultures two hours after induction with ATc. The culture supernatant of the complemented tcdE mutant had a higher concentration of toxin proteins than did the parent strain JIR8094 or the tcdE mutant (Figure 4B). We confirmed by a dot blot experiment with monoclonal antibodies against TcdA that the tcdE gene on pRG60 complements the tcdE mutant (Figure 4C). Thus, these data imply that TcdE is directly required for toxin release.

Figure 4. Complementation of TcdE mutant.

A Growth curve of parent, the TcdE mutant and the complemented TcdE mutant strains. A. The inducer ATc (20 ng/ml) was added to bacterial cultures at 4 hrs after inoculation, indicated by an arrow. The star * indicates the time point when the cultures were harvested for toxin release analysis. B. Toxins were quantified by ELISA from supernatants of bacterial cultures induced by 20 ng/ml ATc for 2 hours. The signal from the test was recorded as absorbance at 450 nm. The data shown are the mean +/− standard error of three replicative samples. C. Dot blots of culture supernatants of the parental, the TcdE mutant and the complemented TcdE mutant, induced or not induced by ATc (0 and 20 ng/ml), with monoclonal anti-TcdA. D. Dot blots of samples in B with monoclonal antibodies against L7/L12 ribosomal subunits.

TcdE-dependent release of toxin is not related to bacterial cell lysis

To test whether TcdE mediates toxin release via cell lysis, we compared the levels of several known cytosolic marker proteins in the tcdE mutant and wild-type strains. No significant difference was seen between the parent strain and the mutant in their levels of cytosolic LDH activity (Figure 3C). In addition, dot blots of cytosolic fractions of overnight cultures (16 hrs) with antibodies to ribosomal subunits (L7/L12) and the RNA polymerase β subunit (see Materials and Methods) showed similar levels of these proteins in the cytosol of the mutant and wild-type strains (Figure 3D). In the complemented tcdE mutant, the amounts of L7/L12 proteins in the culture supernatants were very low and equal to those detected for the parental and tcdE mutant strains (Figure 4D). Finally, we looked for an effect of TcdE expression on C. difficile membrane integrity. We used FACS analysis of cells exposed to the fluorescent nucleotide binding dyes SYTO9 and propidium iodide (PI). SYTO9 is commonly used as a stain for live cells, whereas PI is excluded by the intact cell membrane, thus staining a cell only when the integrity of the membrane has been compromised. When used in combination, cells with intact membranes are labeled green by SYTO9 while membrane-permeablized cells are labeled red by PI. FACS analysis of control samples, containing mixtures of heat-killed and actively growing C. difficile cells, was consistent with the different ratios (1/100, 50/50 and 100/1 of killed/live, respectively) that we used (Figure 5A). When we analysed the mutant and parental strains harvested 16 hrs after inoculation, no significant difference could be observed in the intact vs. membrane-permeable cell populations (Figure 5B). In both strains, the membrane-permeable fraction was negligible indicating minimal cell lysis. Interestingly, cell lysis did occur in a C. difficile tcdA tcdB double mutant strain [26] that produces TcdE, as shown by the loss of absorbance at 600 nm (Figure 6A) and the appearance of red fluorescence (Figure 6B) when compared to the parental and PaLoc negative strains (see the Discussion).

Figure 5. FACS analysis of C. difficile cells for membrane permeability through propidium iodide (PI) and SYTO staining.

A. The viability standard samples containing the heat killed and actively growing C. difficile cells at 1/100, 50/50 and 100/1 ratio, respectively. B. The tcdE mutant and the parent JIR8094 cells collected from the overnight (16 h) cultures, were subjected to FACS analysis following propidium iodide (PI) and SYTO staining.

Figure 6. Cell lysis in C. difficile AB double mutant strain.

A. Growth curves of strains, 630AB (C. difficile tcdAB double mutant), 630E (wild type) and a PaLoc negative strain. C. difficile strains were grown in TY medium in a 100 ml Erlenmeyer flask and the optical density at 600 nms was recorded at regular time interval. B. Bacterial cultures were harvested at a 30 hour time point for FACS analysis after propidium iodide (PI) and SYTO staining.

TcdE can function as a phage holin

Since no bona fide system for assaying holin activity exists in C. difficile, we turned to assays of E. coli λ lysogens expressing TcdE. To test whether TcdE has any holin-like activity, we asked whether TcdE could complement a λ lysogen that has a nonsense mutation (Sam7) in its holin gene but has a functional endolysin gene [27]. We confirmed the functionality of this system using plasmids pJN4 and pJN5 (Figure 7A) expressing, respectively, a μιξτυρε of holin S105 and antiholin S107 or S105 alone from the λ late promoter and the λS RBS [28]. As shown in Figure 8A, thermo-induction of E. coli MC1063 λ (cI857Sam7) containing pJN4 or pJN5 led to complete bacterial lysis after 40 or 70 minutes, respectively, which is in good agreement with published values [18]. No lysis was observed after heat induction of a plasmid-free lysogen or a lysogen carrying the empty vector (Figure 8A).

Figure 7. The holin like TcdE.

A. Constructs used for holin expression under the control of the late transcription regulatory (LTR) elements of phage λ. The promoter pR′ and the transcriptional terminator tR′ of the λ LTR region are depicted as a bent arrow and a hairpin structure, respectively. B. TcdE sequence: all possible translational starts are indicated as Met1, Met25 and Met27, the potential Shine-Dalgarno sequences are underlined and mutated nucleotides in the specified constructs are highlighted in bold.

Figure 8. Testing holin function of TcdE in E. coli.

Lysis curves of lysogenic cultures carrying λcI857Sam7 (A) or λCmrΔ(SR) (B) and plasmids expressing in trans λS, S105,TcdEM1, TcdEM25, and TcdEM27, respectively. A lysogenic strain carrying pBR322 was used as negative control. C. Lysis curve of E. coli λcI857Sam7 lysogen carrying plasmids expressing TcdEM1 in pCD463, TcdEMet1, TcdEMet1', TcdEMet25' and TcdEMet27' respectively. D. FACS analysis of E. coli λCmrΔ(SR) lysogens expressing either S105 or TcdEM1 through propidium idodide (PI) and SYTO9 staining.

When we cloned tcdE in the expression plasmid (see Materials and Methods), we took into account the fact that the actual product of tcdE is unknown. There are three potential ATG start codons in the same reading frame (Figure 7B). The most upstream start codon (Met1) is located 122 bp downstream of the stop codon of the tcdB gene. The second and third potential initiator methionine codons correspond to residues 25 (Met25) and 27 (Met27) of the putative full-length protein (Figure 7B). Thus, sequences encoding all three potential forms of TcdE (tcdEM1) or only M25 and M27 (tcdEM25) or only M27 (tcdEM27), were cloned under the control of the λ PR′ promoter (Figure 7A) [29]. When expressed in E. coli MC1063 λ (cI857Sam7), the TcdEM1 (pCD311) and TcdEM25 (pCD302) forms induced complete bacterial lysis within five minutes after thermo-induction whereas expression of the TcdEM27 form (pCD322) caused complete lysis only at about 40 min. (Figure 8A). As was the case for λS protein, lysis induced by expression of any of the putative forms of TcdE required expression of the λ endolysin. However, when expressed in E. coli λCmrΔ(SR), carrying a deletion in holin and endolysin genes, the λS, TcdEM1, TcdME25 and TcdEM27 forms did not cause lysis (Figure 8B), indicating that the lysis in E. coli could not be due to over-expression of the λS and TcdE forms. It has been shown that an inactive mutated version of ‘S’ protein expressed in E. coli MC1063 λ (cI857Sam7) does not induce host lysis as well [30]. To assess the state of the cytoplasmic membrane in endolysin-deficient cells, we stained the cells with SYTO and PI as described above. Figure 8D shows the plots of green (FL1) and red (FL2) fluorescence of E. coli strains after staining with SYTO and PI dyes before and after thermoinduction. Before thermoinduction, the lysogens appeared to have intact cell membranes. The S105-expressing E. coli λ (CmrΔSR) population lost its membrane integrity nearly 30 minutes after thermoinduction. In TcdEM1 expressing E. coli cells, the membrane was permeabilized within five minutes after thermoinduction, indicating a more rapid damage to the cell membrane (Figure 8D).

Alternative translational motifs in the tcdE gene

The λS gene encodes two proteins with opposing functions. The lethal holin S105 initiates at codon 3 and its inhibitor, S107, initiates at codon 1. The proportion of S105 to S107, normally 2∶1, is determined by an RNA stem-loop structure that includes the ribosome binding site of λS. This dual start motif appears to be a fine-tuning system for the scheduling of host cell lysis during phage infection [29]. Since we observed a significant difference in the timing of lysis mediated by different TcdE forms in E. coli (Figure 8A), we tested the possible roles of the three potential translational start sites in tcdE mRNA by introducing site-directed mutations within the putative start codons. We deleted the λS ribosome binding site, creating the plasmid pBRQ(Δrbs) and then cloned tcdE ORF from first methionine codon with its own ribosome binding site (tcdEMet1) in pBRQ(Δrbs), creating plasmid pRG32 (Figure 7B). When expressed in E. coli MC1063 λ (cI857Sam7), the TcdEMet1 (pRG32) form induced late bacterial lysis (Figure 8C) compared to the rapid lysis phenotype of tcdEM1 expressed from the λS RBS (Figure 8A).

To differentiate the lytic activities of the TcdE derived by initiation at codon 1 from those derived by initiation at codon 25 and 27, we converted methionines M25 and M27 to leucine residues and the protein expressed from this construct pRG35 was designated as TcdEMet1' (Figure 7B). Substitution of methionine by leucine was expected to maintain the hydrophobicity of the protein. Following similar strategies, constructs pRG37 and pRG36 expressing TcdEMet25' and TcdEMet27', respectively, were created by converting methionine M1 into a stop codon and then by changing methionines M27 to L27 in pRG37 and M25 to L25 in pRG36 (Figure 7B, Table 1). The expression of the different TcdE forms (Met1', Met25' and Met27'), was tested by introducing a C-terminal 6xHis Tag into the respective constructs and protein expression was confirmed by Western blotting with anti-His tag antibodies (data not shown). When these versions of TcdE, each of which encodes only a single form of the protein, were expressed in E. coli MC1063 λ (cI857Sam7), we observed major differences in lysis phenotypes (Figure 8C). The TcdEMet1'- and TcdEMet25'- expressing clones initiated lysis within 15 minutes after induction, whereas the TcdEMet27'- expressing clone showed a much slower decrease in OD600 that began at about 25 minutes after induction. Both these results indicate that methionines at codons 1, 25 and 27 can be used as start codons. However, the TcdEMet27' clone induced some lysis but at lesser extent, compared to the two other TcdE forms. Moreover, since the TcdEMet1' and TcdEMet25' clones (neither of which includes methionine 27) induced much more rapid lysis than did TcdEMet1 (which potentially expresses as many as three different TcdE forms) or TcdEMet27', the form of TcdE that initiates at M27 may be both relatively inactive and a potential antiholin analogous to λ S107 when multiple forms of TcdE are produced simultaneously.

Localization of TcdE in E. coli and C. difficile

In E. coli, the λS protein exists in an oligomeric state in the inner membrane [31]. To localize TcdE, we expressed TcdE with a C-terminal 6xHis Tag (pCD463) in E. coli strain MC1063 λCmrΔ(SR), which does not express holin or endolysin (see Materials and Methods). This version of TcdE complemented the λ (cI857Sam7) lysogen (Figure 8C). After induction of TcdE expression, cells were collected and the cytosolic and the inner membrane proteins were separated by SDS-PAGE and analyzed by Western blot with antibodies against the 6xHis Tag or ribosomal proteins L7/L12 or the membrane-bound β subunit of E. coli ATP synthase (Figure 9A). As expected, the ribosomal subunits were detected only in the cytoplasmic fraction and the ATPase β subunit was detected primarily in the membrane fraction. The anti-6xHis Tag antibodies detected TcdE only in the membrane fraction (Figure 9A), indicating that TcdE is exclusively membrane-bound in E. coli.

Figure 9. Localization of TcdE in E. coli and C. difficile.

A. Cytoplasmic and membrane proteins analysis of E. coli lysogens of λCmrΔ(SR) carrying pBR322 (control) or pCD463 (+tcdE-6xHis). B. Cytoplasmic and membrane proteins analysis of C. difficile strain carrying either pMTL84151 (control) or pRG46 (+tcdE-6xHis). (1) SDS-PAGE coomassie stained gel. Western blots probed with 6XHis Tag antibody (2), ATPase Beta subunit antibody (3), and Ribosomal subunits LI/L2 monoclonal antibody (4). C. Membrane protein samples from bacterial cells expressing TcdE-6His resuspended in denature or native sample buffers and analyzed by Western blot using His-Tag antibody. D. Membrane proteins of JIR8094, TcdE mutant and complemented TcdE mutant strains were harvested from bacterial cultures induced with 20 ng/ml of ATc for 2 hours, separated in 16% Tris-Glycine gel and transferred into PVDF membrane. Panels 1. Ponceau stained membrane; 2. Probed with TcdE antibody.

To localize TcdE in C. difficile, we expressed TcdE with a C-terminal 6xHis Tag in a replicative plasmid under the control of the native upstream region (pRG46, see Materials and Methods). Cytosolic and membrane proteins were extracted from the transconjugant and were analyzed by Western blots. The ribosomal proteins L7/L12 were detected only in the cytosolic fractions and the ATPase β subunit only in the membrane fractions (Figure 9B). The anti-6xHis Tag antibodies detected TcdE-6xHis only in the membrane fractions, as was the case in E. coli expressing TcdE. Finally, under non-reducing conditions, i.e. in absence of the reducing agent, we observed that TcdE forms oligomers both in E. coli and in C. difficile (Figure 9C), which is consistent with the status of membrane-associated holins, such as λ holin S105 when they are forming holes [31]. We also analysed the membrane proteins of the complemented TcdE mutant by Western blot using antibodies against TcdE, to evaluate the level of TcdE in JIR8094 strain vs. TcdE complemented strain that we have shown secreting more toxins than the parental strain (Figure 4B). Interestingly, the level of TcdE expressed is higher in the complemented strain than in the wild type strain (Figure 9D). Hence the higher amount of toxin in the supernatant of the complemented tcdE mutant could be due to the higher level of TcdE in the complemented strain.


A role for holins in protein secretion in Gram-positive bacteria has long been suggested without strong experimental evidence [20][22]. We provide here the first genetic evidence that TcdE, an apparent holin, is required for efficient toxin secretion by C. difficile, but that it does so without causing the significant cell lysis or membrane damage usually associated with the phage holins. At the same time, we showed that, when expressed in E. coli, TcdE has properties similar to those of λ S protein, a holin needed for phage release. Thus, any mechanistic model for the role of TcdE in C. difficile toxin secretion has to account for TcdE's inability to cause detectable membrane damage in the natural host. Such models are suggested below.

Holins are extremely diverse, but most can be grouped into two main classes based on the number of predicted transmembrane domains (TMDs) [32]. Analysis of TcdE using the TMHMM program ( suggested the presence of three TMDs, characteristic of class I holins [32] (Figure 1A). Similar to many class I holins, TcdE expressed in E. coli and C. difficile was localized to the cytoplasmic membrane in oligomeric forms. Close homologs of TcdE in Clostridium sordellii (TcsE), and Clostridium perfringens (UviB) could be identified in close proximity to toxin-encoding genes. We expressed these TcsE and UviB downstream of the λ late promoter in E. coli MC1063 λ (cI857Sam7). Similar to TcdE, both TcsE and UviB induced cell lysis upon phage induction (data not shown). Mutagenesis of the genes encoding these TcdE-like proteins will indicate if that they are required for secretion of the lethal toxin of C. sordellii and the bacteriocin of C. perfringens.

Holin-encoding genes and holin activity are subject to several levels of regulation, among which a particularly striking feature is the common occurrence of two potential translational starts separated by only a few codons [18], [33]. The TcdE coding sequence includes three potential start codons at positions 1, 25 and 27. We have tested all three potential TcdE forms (TcdEM1, TcdEM25 and TcdEM27) for their ability to complement a λS mutant phage. The M1 and M25 forms of TcdE induced lysis within a few minutes after phage induction, whereas the M27 form was only able to induce delayed and less abundant lysis. Constructs that permitted simultaneous expression of M27 and M25 or all three forms showed relatively delayed lysis, raising the possibility that M27 is an inhibitory form of TcdE. Detailed experiments are in progress to test the multi-start regulation of TcdE activity in C. difficile.

With TcdE having both structural and biochemical properties of phage holins, we propose several models for the TcdE-dependence of C. difficile toxin secretion. Some holins create pores that are wider than 1 µm [34], while others, called pinholins, make channels only 15 Å in diameter [35]. Detergent-solublized λS105 holin forms ring-like structures containing about 72 monomers with an average inner diameter of 8 nm [36]. If toxins are secreted in an unfolded state, possibly via translationally coupled secretion, only a narrow channel in the cytoplasmic membrane would be needed. Such a channel would not allow cytoplasmic protein leakage. On the other hand, if toxins are secreted as fully folded proteins, a large membrane channel would be needed due to the volumes the large toxin proteins would occupy. Although TcdE has the intrinsic ability to form pores in the membrane that lead to permeability and cell death, as seen in E. coli, it does not do so in C. difficile. If TcdE-dependent pores are formed in C. difficile, they should be tightly regulated by a mechanism that could include the toxins themselves. The toxins could, for instance, act as plugs in the TcdE pore to prevent loss of solutes or proteins from the cells. Such a model is consistent with our observation that a tcdA tcdB double mutant lysed more rapidly than the parental and PaLoc negative strains (Figure 6A). By expressing TcdE at a lower level, C. difficile may also efficiently control cell lysis. We were unable to complement the tcdE mutant using a wild-type gene on a multicopy plasmid, which suggested that TcdE becomes lethal to C. difficile above a certain threshold concentration. This became more evident when we succeeded in complementing the TcdE mutant using a controlled expression vector. Hyper induction driven by high concentrations of the inducer (>50 ng/ml) and prolonged induction of TcdE in C. difficile affected the bacterial growth (Figure 4A and data not shown). Hence under natural conditions C. difficile presumably expresses an amount of TcdE sufficient to form pores that allow release of toxin without causing cell lysis.

Finally, TcdE-dependent channels might be formed in association with other proteins that control the opening of the pore or TcdE could form a specific, gated channel that only opens in the presence of TcdA/TcdB, without inducing cell lysis. None of these models are mutually exclusive; multiple mechanisms may contribute to toxin secretion without inducing cell lysis in C. difficile. Physiologically, it is also more appropriate for C. difficile to release its toxins without killing itself, since the goal of toxin secretion is presumably to increase the survival and dispersion of C. difficile. The detailed, mechanistic understanding of the holin-dependent systems that mediate toxin secretion by Clostridium spp. will be an important advance in understanding how Gram-positive pathogens efficiently release important proteins outside the cell in the absence of known secretion and export signals.

Recently, Olling and collaborators [37] concluded that toxin release was correlated with bacteriolysis, but not with TcdE expression. These results are in direct contradiction with those presented here. Whereas this discrepancy might be attributable to differences in experimental conditions used by the two groups (e.g., glucose-containing BHI medium vs. TY), they are more likely due to differences between the two parental strains used and differences in the time points used for analysis. We have measured the effect of TcdE in late exponential and early stationary phase, whereas the analysis of Olling et al. was primarily restricted to very late time points. Although both strains are erythromycin-sensitive derivatives of strain 630, they were isolated independently and have been maintained through multiple sub-cultures. As discovered by N. Minton and coll. (personal communication), the two extant Erms 630 strains have acquired a number of divergent mutations, some of which might obscure evidence of the role of TcdE in toxin secretion at late exponential growth phase. Contrasting results with these strains were also seen in studies of the roles of the individual toxins in C. difficile pathogenesis [26], [38]. We also note that Olling et al. reported two independent tcdE mutants that behaved somewhat differently, suggesting that at least one of the strains had acquired an additional mutation(s).

Materials and Methods

Bacterial strains and growth conditions

C. difficile strains JIR8094 [39] and its tcdE mutant as well as C. difficile strains 630 delta erm and its AB mutant [26], were grown anaerobically (10% H2, 10% CO2 and 80% N2) in TY broth or TY agar as described previously [8]. E. coli strain HB101 (pRK24) used for conjugation was cultured aerobically in 2×YT. When necessary, E. coli cultures were supplemented with chloramphenicol or ampicillin, at 30 µg ml−1 and 100 µg ml−1, respectively. All routine plasmid constructions were carried out using standard procedures.

Construction of a tcdE knockout mutant

The tcdE mutant was generated in C. difficile JIR8094 by insertion of the bacterial group II intron using the ClosTron gene knockout system as described by Heap et al. [24]. The insertion site, in antisense orientation between nucleotides 234–235 of the tcdE ORF, was selected to design intron-retargeting primers (Table 2). Plasmid retargeting was carried out as described [24]. The resulting plasmid, pTUM007:Cdi-tcdE-234a, was transferred to C. difficile JIR8094 strain by conjugation as described previously [40]. Thiamphenicol-resistant transconjugants were resuspended in 200 µl of TY broth and plated on TY agar plates containing erythromycin (5 µg ml−1) to select potential Ll.ltrB insertions. Then the putative tcdE mutants were screened by PCR using tcdE-specific primers (OBD231, OBD232) in combination with the EBS-U universal and ERM primers (Table 2). The selected mutant was further characterized by sequencing PCR products amplified using ODB231-232 and EBS-U, and designated strain JIR8094 tcdE mutant.

Southern hybridization.

Genomic C. difficile DNA were digested with EcoRV and HindIII and subjected to agarose gel electrophoresis (0.8%). The DNA were then transferred from the gel onto Hybond-N+ filter (Amersham) in 20X saline citrate according to the method of Southern. Filter was prehybridized for 2 h at 42°C in 50% formamide, 5X SSC, 2x Denhart's solution and 100 mg of denatured salmon sperm DNA per ml. Overnight hybridization was carried out in the same solution at 42°C with a nick-translated intron fragment (OBD522–OBD523, Table 2). The filter was washed 30 min in 1×SSC, 0,1%SDS and 30 min in 0.1×SSC, 0,1%SDS at room temperature before it was air dried and exposed to Amersham Hyperfilm MP.

C. difficile toxin and Lactate dehydrogenase (LDH) assays

Culture supernatants were collected and filtered, and the cell pellets were resuspended in 10 mM Tris buffer, pH 8.0 containing a protease inhibitor cocktail (Roche, Mannheim, Germany). The cytosolic contents were obtained by sonication of the cells, followed by brief centrifugation to removed unbroken cells and cell debris. Total protein concentration was determined using the Bio-Rad protein assay reagent. Equal amounts of cytosolic and supernatant proteins were assayed for their relative toxin contents using the ELISA kit following the manufacturer's directions. LDH activity was determined using the CytoTox 96 kit from Promega (Madison, WI, USA) and toxins were measured using the Premier Toxin A&B Enzyme linked Immunoassay (ELISA) kit from Meridian Diagnostics Inc., [Cincinnati, Ohio].

Dot blots to detect Toxin A, Toxin B, RNA polymerase and ribosomal subunits

Culture supernatants collected from the parent and the mutant strains were concentrated by passage through Amicon Microcon (YM-100) columns. The cytosolic proteins were prepared by sonication followed by brief centrifugation. To detect TcdA and TcdB, 200 ng of total protein was spotted on nitrocellulose filters (Amersham Pharmacia) and probed with monoclonal antibodies raised against Toxin A [41] and Toxin B (a generous gift from Dr. Feng, University of Maryland). For other blots, two-fold dilutions of C. difficile cytosolic proteins were spotted and probed with monoclonal antibodies raised against the E. coli RNA polymerase beta subunit (NeoClone Biotechnology) or streptococcal L7/L12 ribosomal subunits [42]. Following incubation with anti-mouse horseradish peroxidase-conjugated antibody, the antigen-antibody complexes were detected using ECL Western blotting detection reagents (Pierce).

FACS analysis

Bacterial cells were washed with 0.9% NaCl and stained with SYTO9 and Propidium Idodide (PI), mixed in equal proportions, for 5 min. Overnight cultures of C. difficile were stained under anaerobic conditions. The thermo-induced E. coli cells were chilled on ice before processing for staining. Flow cytometry was performed immediately after staining with a FACS Calibur (Becton Dickinson, San Jose, Calif.) equipped with an air-cooled 15-mW argon ion laser operating at 488 nm. The green fluorescence of the SYTO dye (FL1) was collected using a 530- ±30-nm band-pass filter; the red fluorescence emitted from PI (FL2 or FL3) was collected using a 630- ±10-nm band-pass filter. Control samples were used for the instrument settings (voltage of the detectors and the compensation) and consisted of unlabeled cells, heat-killed bacterial cells stained with PI (FL3 or FL2), and SYTO (FL1). Bacterial cells were discriminated from electronic noise using a double threshold set on both side scatter (SSC) and forward scatter (FSC), with FSC set on E01 and SSC set on 400V. The data were analyzed with the CellQuest software from Becton Dickinson. All parameters were measured using logarithmic amplification.

Complementation of C. difficile tcdE mutant

The tcdE ORF along with its RBS was PCR amplified from JIR8094 chromosomal DNA using primers ORG102 and ORG103, which carried restriction sites SacI and BamHI, respectively. The resulted PCR product was digested with SacI and BamHI enzymes and cloned into the vector pRPF185 [25], placing the tcdE gene under a tetracycline inducible promoter. The resulting plasmid pRG60, was then introduced into JIR8094 and tcdE mutant C. difficile strains by conjugation. Transconjugants carrying either pRG60 or the vector pRPF185 were grown overnight in TY medium supplemented with thiamphenicol. 100 ml of fresh cultures were inoculated with 1 ml of overnight cultures and were grown for 4 hours in TY medium with thioamphenicol before to be induction with 20 ng/ml ATc. Culture supernatants were harvested for the detection of released toxins using ELISA or dot blot analysis using monoclonal antibody against TcdA.

TcdE expression under the control of phage λ regulatory elements

Plasmids pJN4 and pJN5, derivatives of pBR322 that carry the λ genes of Sλ (encoding holin S105 and antiholin S107) or S105, respectively, were used to create constructs in which the tcdE gene was placed under the control of the λ pR′ promoter (late transcription regulatory (LTR) region, spanning from the 3′ end of the antiterminator Q gene to the first bp of the S holin gene) [28]. Three different forms of the tcdE coding sequence, known as tcdEM1, tcdEM25 and tcdEM27 (Figure 6B), were PCR amplified using forward primers OBD231, OBD256 and OBD294, respectively (Table 2) along with the reverse primer OBD232, digested and ligated to pJN5 to create plasmids pCD311 (tcdEMI), pCD302 (tcdEM25) and pCD322 (tcdEM27). Using site-directed mutagenesis ((Stratagene Quick change mutagenesis kit), the Sλ gene ribosomal binding site (RBS) was deleted in plasmid pJN4 to create plasmid pBRQ(Δrbs). To express TcdE with its own ribosomal binding site, the tcdEM1 gene was PCR amplified using primers ORGE1 and OBD232 and the product (tcdEMet1) was cloned into pBRQ(Δrbs), creating plasmid pRG32. Site-directed mutagenesis was performed in pRG32 to introduce mutations in the TcdE coding regions and resulted in plasmids pRG35, pRG36 and pRG37 (Table 1, Figure 6C). In order to test TcdE holin activity, lysogens of E. coli strain MC1061 for a defective λ prophage bearing a nonsense mutation in its holin gene (Sam7) or carrying a deletion in holin and endolysin genes [λCmrΔ(SR)] were used as hosts for these plasmid constructs. Both λ (Sam7) and λCmrΔ(SR) encode a thermo-sensitive CI repressor (cI857) and are induced upon shifting the culture temperature from 30°C to 37°C [27]. Resultant strains were grown in LB broth at 30°C until the OD600 reached 0.15–0.2 before thermo-induction of the λ prophage at 42°C for 15 min. Bacterial growth and lysis at 37°C were then followed by monitoring the absorbance at 600 nm at 5 min intervals.

Localization of TcdE in E. coli

To fuse a 6xHis Tag to the C-terminus of TcdEM1, the tcdEM1 was amplified with primer OBD418 and OBD419 (Table 2), digested and cloned in pIVEX2.3d (Roche Applied Science) to create pCD429. Then, a 6xHis Tag fused to tcdEM1 was amplified from pCD429 DNA using OBD488 and OBD490 (Table 2), digested and ligated to pJN5 creating plasmid pCD463. The plasmids pCD463 and pBR322 were introduced into E. coli strain MC1061:: λCmrΔ(SR) and the cultures were grown in LB broth at 30°C until the OD600 reached 0.8–1.0 before the thermo induction (15 min at 42°C) and was then kept at 37°C for two more hours. The cells were then harvested by centrifugation, resuspended in 0.05 M Tris-HCl, pH 7.5, containing a protease inhibitor cocktail (Sigma), and disrupted by passage through a French pressure cell at 10000 psi. The inner membrane and the cytosolic proteins were prepared as described [29]. Equal amounts of inner membrane and cytosolic proteins were separated on a SDS-PAGE gel and Western blots were performed with antibodies against the 6xHis Tag (Bio-Design International), E. coli ATPase β subunit [43] and streptococcal ribosomal proteins L7 and L12 [42].

Localization of TcdE in C. difficile

The tcdE gene, along with 600 bp of the upstream region, was amplified with primers OBD444 and OBD445 introducing a C-terminal 6xHis Tag (Table 2). The PCR product was cloned in the clostridial conjugative vector pMTL84151 to create plasmid pRG46, which was introduced by conjugation into C. difficile strain N04-799 (National Microbiology Laboratory, Manitoba, Canada), a ribotype 027 strain. Transconjugants carrying either pRG46 or the vector pMTL84151 alone were grown overnight in TY medium supplemented with thiamphenicol. Cytosolic and membrane proteins were prepared as described before [44]. Membrane protein samples from bacterial cells expressing TcdE-6His were denatured by resuspending them in sample buffer with DTT and were boiled for 5 minutes before loading into 4–20% gradient Tris-Glycine gel. Under non-reducing conditions, membrane proteins were resuspended in sample buffer in the absence of the reducing agent (DTT) and were not boiled before loading into the gel. After separation the proteins were transferred into PVDF membrane and were probed with antibodies against the 6-His Tag or TcdE as described earlier [37].

Supporting Information

Figure S1.

Comparative analysis of toxin B production by JIR8094 and tcdE mutant strains. African green monkey kidney (Vero) cells, were cultured in Dulbecco's modified Eagle's medium (DMEM, Gibco) supplemented with 5% fetal calf serum (PAA), 50 U/ml penicillin and 50 µg/ml streptomycin (Gibco) at 37°C in a 5% CO2 atmosphere. Cells were grown until confluence in 96-well plates. Supernatants from 12 hours old bacterial cultures were used for the cytotoxicity assay. The monolayers were incubated with 2-fold serially diluted in DMEM of supernatants. After 24 h at 37°C, cytotoxicity was assessed by examination using an optical microscope. A positive result was considered when more than 50% of cells showed a cytotoxic effect (characteristic rounding of Vero cells). The data shown are the mean +/− standard error of three replicative samples.



We thank Linc Sonenshein, Tufts University, for advice and assistance with the manuscript; Ry Young, Texas A&M University, for helpful advice on holin experiments and E. coli strain MC1063 λCmrΔ(SR); Mario Manuel Santos and João G.Nascimento, Universidade de Lisboa for advice and plasmids pJN4 and pJN5 as well as E. coli MC1063 λ (cI857Sam7) strain; John Heap, University of Nottingham, for the plasmids pMTL007 and pMTL84151; Sarah Kuehne and Nigel Minton, University of Nottingham, for the C. difficile strains 630 delta erm and its AB mutant; Gerhard R and Alexandra Olling, Hannover Medical School for their generous gift of TcdE antibodies; Robert Fagan and Neil Fairweather, Imperial college of London for C. difficile controlled expression vector pRPF185; Hanping Feng, University of Maryland for TcdB monoclonal antibodies and Stephen Melville for critical comments.

Author Contributions

Conceived and designed the experiments: RG BD. Performed the experiments: RG BD. Analyzed the data: RG BD. Contributed reagents/materials/analysis tools: RG BD. Wrote the paper: RG BD.


  1. 1. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442–2449.
  2. 2. Pepin J, Valiquette L, Alary ME, Villemure P, Pelletier A, et al. (2004) Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171: 466–472.
  3. 3. Burdon DW, George RH, Mogg GA, Arabi Y, Thompson H, et al. (1981) Faecal toxin and severity of antibiotic-associated pseudomembranous colitis. J Clin Pathol 34: 548–551.
  4. 4. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, et al. (1995) Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500–503.
  5. 5. Just I, Gerhard R (2004) Large clostridial cytotoxins. Rev Physiol Biochem Pharmacol 152: 23–47.
  6. 6. Schirmer J, Aktories K (2004) Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim Biophys Acta 1673: 66–74.
  7. 7. Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL (2007) Repression of Clostridium difficile toxin gene expression by CodY. Mol Microbiol 66: 206–219.
  8. 8. Dupuy B, Sonenshein AL (1998) Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27: 107–120.
  9. 9. Hammond GA, Johnson JL (1995) The toxigenic element of Clostridium difficile strain VPI 10463. Microb Pathog 19: 203–213.
  10. 10. Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, et al. (1997) Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem 244: 735–742.
  11. 11. Just I, Wilm M, Selzer J, Rex G, von Eichel-Streiber C, et al. (1995) The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270: 13932–13936.
  12. 12. Mani N, Dupuy B (2001) Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci U S A 98: 5844–5849.
  13. 13. Natale P, Bruser T, Driessen AJ (2008) Sec- and Tat-mediated protein secretion across the bacterial cytoplasmic membrane–distinct translocases and mechanisms. Biochim Biophys Acta 1778: 1735–1756.
  14. 14. Mukherjee K, Karlsson S, Burman LG, Akerlund T (2002) Proteins released during high toxin production in Clostridium difficile. Microbiology 148: 2245–2253.
  15. 15. Matamouros S, England P, Dupuy B (2007) Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol Microbiol 64: 1274–1288.
  16. 16. Moncrief JS, Barroso LA, Wilkins TD (1997) Positive regulation of Clostridium difficile toxins. Infect Immun 65: 1105–1108.
  17. 17. Tan KS, Wee BY, Song KP (2001) Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. J Med Microbiol 50: 613–619.
  18. 18. Wang IN, Smith DL, Young R (2000) Holins: the protein clocks of bacteriophage infections. Annu Rev Microbiol 54: 799–825.
  19. 19. Young I, Wang I, Roof WD (2000) Phages will out: strategies of host cell lysis. Trends Microbiol 8: 120–128.
  20. 20. Desvaux M, Hebraud M (2006) The protein secretion systems in Listeria: inside out bacterial virulence. FEMS Microbiol Rev 30: 774–805.
  21. 21. Desvaux M, Hebraud M, Talon R, Henderson IR (2009) Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue. Trends Microbiol 17: 139–145.
  22. 22. Desvaux M, Khan A, Beatson SA, Scott-Tucker A, Henderson IR (2005) Protein secretion systems in Fusobacterium nucleatum: genomic identification of Type 4 piliation and complete Type V pathways brings new insight into mechanisms of pathogenesis. Biochim Biophys Acta 1713: 92–112.
  23. 23. Desvaux M, Khan A, Scott-Tucker A, Chaudhuri RR, Pallen MJ, et al. (2005) Genomic analysis of the protein secretion systems in Clostridium acetobutylicum ATCC 824. Biochim Biophys Acta 1745: 223–253.
  24. 24. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP (2007) The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods 70: 452–464.
  25. 25. Fagan RP, Fairweather NF (2011) Clostridium difficile has two parallel and essential Sec secretion systems. J Biol Chem 286: 27483–27493.
  26. 26. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, et al. (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 467: 711–713.
  27. 27. Smith DL, Young R (1998) Oligohistidine tag mutagenesis of the lambda holin gene. J Bacteriol 180: 4199–4211.
  28. 28. Sao-Jose C, Santos S, Nascimento J, Brito-Madurro AG, Parreira R, et al. (2004) Diversity in the lysis-integration region of oenophage genomes and evidence for multiple tRNA loci, as targets for prophage integration in Oenococcus oeni. Virology 325: 82–95.
  29. 29. Chang CY, Nam K, Young R (1995) S gene expression and the timing of lysis by bacteriophage lambda. J Bacteriol 177: 3283–3294.
  30. 30. White R, Chiba S, Pang T, Dewey JS, Savva CG, et al. (2011) Holin triggering in real time. Proc Natl Acad Sci U S A 108: 798–803.
  31. 31. Grundling A, Blasi U, Young R (2000) Genetic and biochemical analysis of dimer and oligomer interactions of the lambda S holin. J Bacteriol 182: 6082–6090.
  32. 32. Young R (2002) Bacteriophage holins: deadly diversity. J Mol Microbiol Biotechnol 4: 21–36.
  33. 33. Blasi U, Young R (1996) Two beginnings for a single purpose: the dual-start holins in the regulation of phage lysis. Mol Microbiol 21: 675–682.
  34. 34. Dewey JS, Savva CG, White RL, Vitha S, Holzenburg A, et al. Micron-scale holes terminate the phage infection cycle. Proc Natl Acad Sci U S A 107: 2219–2223.
  35. 35. Pang T, Savva CG, Fleming KG, Struck DK, Young R (2009) Structure of the lethal phage pinhole. Proc Natl Acad Sci U S A 106: 18966–18971.
  36. 36. Savva CG, Dewey JS, Deaton J, White RL, Struck DK, et al. (2008) The holin of bacteriophage lambda forms rings with large diameter. Mol Microbiol 69: 784–793.
  37. 37. Olling A, Seehase S, Minton NP, Tatge H, Schroter S, et al. (2012) Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Microb Pathog 52: 92–100.
  38. 38. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, et al. (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176–1179.
  39. 39. O'Connor JR, Lyras D, Farrow KA, Adams V, Powell DR, et al. (2006) Construction and analysis of chromosomal Clostridium difficile mutants. Mol Microbiol 61: 1335–1351.
  40. 40. Purdy D, O'Keeffe TA, Elmore M, Herbert M, McLeod A, et al. (2002) Conjugative transfer of clostridial shuttle vectors from Escherichia coli to Clostridium difficile through circumvention of the restriction barrier. Mol Microbiol 46: 439–452.
  41. 41. Lyerly DM, Phelps CJ, Wilkins TD (1985) Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol 21: 12–14.
  42. 42. Kolberg J, Hoiby EA, Lopez R, Sletten K (1997) Monoclonal antibodies against Streptococcus pneumoniae detect epitopes on eubacterial ribosomal proteins L7/L12 and on streptococcal elongation factor Ts. Microbiology 143(Pt 1): 55–61.
  43. 43. Deckers-Hebestreit G, Altendorf K (1986) Accessibility of F0 subunits from Escherichia coli ATP synthase. A study with subunit specific antisera. Eur J Biochem 161: 225–231.
  44. 44. Govind R, Vediyappan G, Rolfe RD, Fralick JA (2006) Evidence that Clostridium difficile TcdC is a membrane-associated protein. J Bacteriol 188: 3716–3720.
  45. 45. Goldberg AR, Howe M (1969) New mutations in the S cistron of bacteriophage lambda affecting host cell lysis. Virology 38: 200–202.